OR WAIT null SECS
April 09, 2025
Article
Study findings suggest significant socioeconomic disparities in preemptive kidney transplantation rates in children and the need for targeted interventions.
April 08, 2025
Our Q1 recap for nephrology spotlights regulatory updates, new clinical trial data, and advancements in xenotransplant.
April 04, 2025
Using CURE-CKD Registry data, the analysis showed relatively rapid-onset CKD was common in people with prediabetes, especially with hypertension or ASCVD.
April 02, 2025
The March 2025 month in review spotlights a new episode of Crisis Point about CKD for National Kidney Month and renal FDA news.
April 01, 2025
Study findings suggest COVID-19 is linked to a greater risk of long-term kidney dysfunction and new-onset advanced CKD than influenza.
The first quarter of 2025 saw approvals in diabetes, depression, kidney disease, and pain, among others. Read more about high-impact approvals of Q1 now.
March 31, 2025
This FDA News Month in Review provides a round-up of regulatory decisions from March 2025.
March 29, 2025
Four-year results from SOUL at ACC.25 were the first to test the cardiovascular benefits of an oral GLP-1 RA in high-risk type 2 diabetes.
March 21, 2025
Video
Bhatt previews 3 late-breaking clinical trials being presented at this year's American College of Cardiology Annual Scientific Sessions.
March 20, 2025
The March 2025 approval for iptacopan marks the first for C3 glomerulopathy and is based on the APPEAR-C3G trial.
